Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan
- 1 December 2003
- journal article
- observation
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 46 (12), 1713-1714
- https://doi.org/10.1007/s00125-003-1241-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxanDiabetologia, 2002
- Species Differences in Susceptibility of Transplanted and Cultured Pancreatic Islets to the β-Cell Toxin AlloxanGeneral and Comparative Endocrinology, 2001
- Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocinDiabetologia, 2000
- Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing CellsDiabetes, 1997
- Differences in the Expression of Heat-Shock Proteins and Antioxidant Enzymes between Human and Rodent Pancreatic Islets: Implications for the Pathogenesis of Insulin-Dependent Diabetes MellitusMolecular Medicine, 1995
- Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.JCI Insight, 1995
- Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Mechanisms of streptozotocin- and alloxan-induced damage in rat B cellsDiabetologia, 1984
- Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cellsJournal of Endocrinological Investigation, 1979
- Drugs producing diabetes through damage of the insulin secreting cells.1970